- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829864
Supporting the Transition to and Engagement in Parenthood (STEP)
June 13, 2022 updated by: Nicolas Berthelot, Université du Québec à Trois-Rivières
Phase 2 of STEP (Supporting the Transition to and Engagement in Parenthood): A Prenatal Intervention for Women Who Experienced Childhood Trauma
STEP (Supporting the Transition to and Engagement in Parenthood) is a manualized group intervention for pregnant women exposed to early life adversity designed to foster emotion regulation and reflective capacities in participants.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1C3S2
- Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale
-
Trois-Rivières, Quebec, Canada, G6P 6N2
- Centre intégré de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women ages 18+ years
- Interested in reflecting about their experience of pregnancy and willing to attend weekly sessions in group setting.
- Must speak French as their first language
Exclusion Criteria:
- Severe psychiatric disorders (schizophrenia, bipolar disorder)
- Severe emotional dysregulation
- Current self-harm
- Not sure to keep the child
- High level of hostility
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual prenatal cares
Participants of the comparison group will receive usual prenatal cares (ex.
prenatal classes)
|
|
Experimental: STEP
Participants will participate, online or in-person, to the 8-9 sessions of the program addressing the psychological experience of pregnancy and supporting reflective capacities in relation to trauma and motherhood.
|
The program is offered by two facilitators to groups of three to seven women, in-person or online.
The program is divided in three phases entitles "Becoming a mother"; "A look at my own history" and "Looking ahead".
The first phase aims to explore and normalize the emotions experienced by the participants in the course of their pregnancy and to support the use of healthy emotion regulation strategies.
The second phase aims to support mentalization of trauma, by discussing the nature of trauma and its impact; by validating participants' feelings as understandable responses to trauma; by supporting a reflection on positive and harsh experiences with significant others and the ways both types of experiences influenced participants' mental states; and identifying how participants coped with trauma.
In the last phase, discussions focus on participants' needs and strengths, on available resources to support resilience and envision positive and challenging moments with the child.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perception of change in domains of functioning during pregnancy
Time Frame: Administered at one time-point, at the end of the third trimester of pregnancy. The participant will report on perceived changes during the last 9 months.
|
We developed an instrument assessing one's perception of change (negative change to positive change) across multiple domains of functioning including the quality of the relationship with the partner; the quality of the relationship with significant others, self-esteem; emotion recognition, regulation and expression; social support and parental confidence.
These domains will be assessed separately.
|
Administered at one time-point, at the end of the third trimester of pregnancy. The participant will report on perceived changes during the last 9 months.
|
Level of satisfaction concerning the intervention
Time Frame: Satisfaction assessed after each session of the program and after its ending. Satisfaction is thus assessed between the second trimester of pregnancy and 36-weeks of pregnancy, for a total time frame up to 7-months.
|
Participants are invited to complete a self-report questionnaire assessing their level of satisfaction after each session and at the end of the program, using a Likert scale.
A semi-structured interview is also administered at the end of the program that will provide qualitative information regarding their appreciation of the program.
|
Satisfaction assessed after each session of the program and after its ending. Satisfaction is thus assessed between the second trimester of pregnancy and 36-weeks of pregnancy, for a total time frame up to 7-months.
|
Change in psychological distress from baseline (2nd trimester of pregnancy) to the end of the third trimester of pregnancy (around 36 weeks) and from baseline to 6-months postpartum
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Participants are invited to complete a self-report questionnaire (Kessler Distress Scale) assessing psychological distress.
Change between baseline and end of pregnancy will be assessed, as well as between baseline and 6-month postpartum,
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Prenatal reflective functioning
Time Frame: Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of reflective functions.
|
Participants will complete the Pregnancy Interview at the end of the third trimester of pregnancy.
The interview will be subsequently coded for prenatal reflective functioning.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of reflective functions.
|
Parental reflective functioning
Time Frame: Administered at one time-point, at 6-moths postpartum. The measure will assess current level of reflective functions.
|
Participants will complete the Parental Reflective Functioning Questionnaire at 6 months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at 6-moths postpartum. The measure will assess current level of reflective functions.
|
Change in trauma-specific reflective functioning
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
The Failure to mentalize trauma questionnaire (FMTQ) will be administered at baseline, at the end of the third trimester of pregnancy and at 6-months postpartum.
Change between time-points will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Change in trauma-specific reflective functioning
Time Frame: Administered at one time-point, at 6-moths postpartum. The measure will assess current level of reflective functions.
|
Participants will participate to the Trauma Meaning Making Interview (TMMI) at 6-months postnatal.
The interview will be subsequently coded for trauma-specific reflective functioning.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at 6-moths postpartum. The measure will assess current level of reflective functions.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in perception of parental competence
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. The assessment time frame thus covers a period of 7 months.
|
Participants are invited to complete a self-report questionnaire of maternal confidence (Maternal confidence questionnaire).
Change between baseline and the end of pregnancy will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. The assessment time frame thus covers a period of 7 months.
|
Change in post-traumatic stress symptoms from baseline (2nd trimester of pregnancy) to the end of the third trimester of pregnancy (around 36 weeks) and from baseline to 6-months postpartum
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Participants are invited to complete a self-report questionnaire of PTSD symptoms (Post-traumatic checklist for DSM-5).
Change between baseline and the end of pregnancy will be assessed as well as between baseline and 6-months postpartum
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Change in anger from baseline (2nd trimester of pregnancy) to the end of the third trimester of pregnancy (around 36 weeks) and from baseline to 6-months postpartum
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Participants are invited to complete a self-report questionnaire of anger states (STAXI).
Change between baseline and the end of pregnancy will be assessed as well as between baseline and 6-months postpartum
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Change in antenatal attachment
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. he assessment time frame thus covers a period of 7 months.
|
Participants are invited to complete a self-report questionnaire of antenatal attachment (Maternal antenatal attachment scale).
Change between baseline and the end of pregnancy will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. he assessment time frame thus covers a period of 7 months.
|
Self-compassion
Time Frame: Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of self-compassion.
|
Participants are invited to complete a self-report questionnaire of self-compassion at the end of the third trimester of pregnancy.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of self-compassion.
|
Connection to care
Time Frame: From the third trimester of pregnancy to 6 months postpartum. The assessment time frame thus covers a period of 7 months.
|
Participants will be referred to community agencies for resources based on need during their participation to STEP.
Their utilization of other resources will be assessed using self-reported questionnaires at the end of the third trimester of pregnancy and at 6 months postpartum
|
From the third trimester of pregnancy to 6 months postpartum. The assessment time frame thus covers a period of 7 months.
|
Change in emotion regulation strategies
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. he assessment time frame thus covers a period of 7 months.
|
Participants are invited to complete a self-report questionnaire of emotion regulation strategies (CERQ).
Change between baseline and the end of pregnancy, as well as between baseline and 6 months postpartum will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy) and at 36-weeks of pregnancy. he assessment time frame thus covers a period of 7 months.
|
Post-traumatic growth
Time Frame: Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of post-traumatic growth.
|
Participants are invited to complete a self-report questionnaire of post-traumatic growth at the end of the third trimester of pregnancy.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the end of the third trimester of pregnancy. The measure will assess current level of post-traumatic growth.
|
Parental stress
Time Frame: Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of parental stress.
|
Participants are invited to complete a self-report questionnaire of parental stress at 6-months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of parental stress.
|
Maternal bonding
Time Frame: Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of maternal bonding.
|
Participants are invited to complete a self-report questionnaire of maternal bonding at 6-months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of maternal bonding.
|
Maternal competence
Time Frame: Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of perceived maternal competence..
|
Participants are invited to complete a self-report questionnaire of maternal sense of competence at 6-months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention.
|
Administered at one time-point, at the 6-months postpartum assessment. The measure will assess current level of perceived maternal competence..
|
Depression
Time Frame: Data will be collected at 36-weeks of pregnancy and at 6-months postpartum. The assessment time frame thus covers a period of 7 months.
|
Participants are invited to complete a self-report questionnaire of post-partum depression at the end of the third trimester of pregnancy and at 6-months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention separately for each time point.
|
Data will be collected at 36-weeks of pregnancy and at 6-months postpartum. The assessment time frame thus covers a period of 7 months.
|
Maternal behaviors
Time Frame: Administered at one time-point, around 12-months postpartum. The measure will assess current maternal behaviors..
|
Mother-infant interactions will be realized and videotaped for subsequent coding of maternal behaviors around 12-months postpartum.
Scores in participants to the intervention will be compared to scores of matched controls who did not participate to the intervention
|
Administered at one time-point, around 12-months postpartum. The measure will assess current maternal behaviors..
|
Change in affective states from baseline (2nd trimester of pregnancy) to the end of the third trimester of pregnancy (around 36 weeks) and from baseline to 6-months postpartum
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Participants are invited to complete a self-report questionnaire (Positive and Negative Affect Scale) assessing positive and negative affects.
Change between baseline and end of pregnancy will be assessed as well as between baseline and 6-month postpartum,
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Infant general development
Time Frame: Administered at one time-point, at 6-moths postpartum. The measure will assess current level of infant development.
|
The ASQ-3 will be administered at 6-months postnatal to assess infant development.
|
Administered at one time-point, at 6-moths postpartum. The measure will assess current level of infant development.
|
Infant socio-emotional development
Time Frame: Administered at one time-point, at 6-moths postpartum. The measure will assess current level of infant development.
|
The ASQ-SE will be administered at 6-months postnatal to assess infant socio-emotional development.
|
Administered at one time-point, at 6-moths postpartum. The measure will assess current level of infant development.
|
Infant temperament
Time Frame: Administered at one time-point, at 6-moths postpartum.The measure will assess current infant temperament
|
The IBQ will be administered at 6-months postnatal to assess infant temperament
|
Administered at one time-point, at 6-moths postpartum.The measure will assess current infant temperament
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Inflammation
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Inflammation will be assessed using blood samples at baseline, at the end of the third trimester of pregnancy and around 6 months postpartum.
Change between baseline and the end of pregnancy, as well as between baseline and 6 months postpartum will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Change in cortisol
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Systemic cortisol will be assessed using blood samples at baseline, at the end of the third trimester of pregnancy and around 6 months postpartum.
Change between baseline and the end of pregnancy, as well as between baseline and 6 months postpartum will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Personality dysfunctions
Time Frame: Administered at one time-point, at the second trimester of pregnancy. The measure will assess current level of personality dysfunctions.
|
Personality dysfunctions are assessed at baseline and will be considered as a moderator of the intervention effectiveness.
Personality dysfunctions will be measured using the Self and Interpersonal Functioning Rating Scale, a 24-item self-report questionnaire designed to assess the four core elements of personality pathology (Identity, Self-direction, Empathy, and Intimacy) from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Level of Personality Functioning for personality disorders
|
Administered at one time-point, at the second trimester of pregnancy. The measure will assess current level of personality dysfunctions.
|
Change in intimate partner violence
Time Frame: Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Participants are invited to complete a self-report questionnaire of intimate partner violence.
Change between baseline and 6 months postpartum will be assessed.
|
Data will be collected at recruitment (2nd trimester of pregnancy), at 36-weeks of pregnancy and at 6-months postnatal. The assessment time frame thus covers a period of 13 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2018
Primary Completion (Actual)
March 15, 2022
Study Completion (Anticipated)
May 15, 2023
Study Registration Dates
First Submitted
March 4, 2021
First Submitted That Met QC Criteria
March 31, 2021
First Posted (Actual)
April 2, 2021
Study Record Updates
Last Update Posted (Actual)
June 14, 2022
Last Update Submitted That Met QC Criteria
June 13, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STEP Phase 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Issue
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Hospices Civils de LyonNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Stanford UniversityNot yet recruitingMental Health Issue
-
The Hong Kong Polytechnic UniversityRecruiting
-
Weill Medical College of Cornell UniversityDoris Duke Charitable FoundationNot yet recruiting
-
Yale UniversityEmpowerment to Heal - Uganda; Empower Through HealthRecruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Dr. Nazanin AlaviWithdrawnMental Health IssueCanada
-
Northwestern UniversityWithdrawnMental Health IssueUnited States
Clinical Trials on STEP
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Reuth Rehabilitation HospitalCompletedAcquired Brain InjuryIsrael
-
Friends Research Institute, Inc.Baylor College of Medicine; Children's Hospital of Philadelphia; San Diego State... and other collaboratorsCompleted
-
Pro-Change Behavior SystemsCompletedSmoking Cessation | Poor Nutrition | Life Stress
-
Region StockholmKarolinska InstitutetActive, not recruiting
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmNot yet recruiting
-
Taisho Pharmaceutical Co., Ltd.CompletedHealthy VolunteerJapan
-
Rush University Medical CenterUniversity of Illinois at Chicago; Michigan State UniversityActive, not recruitingPhysical ActivityUnited States
-
University Hospital, MontpellierDirection Générale de l'Offre de SoinsNot yet recruitingNeurodevelopmental Disorders | Autism Spectrum Disorder | SiblingsFrance
-
VU University of AmsterdamFreie Universität Berlin; World Health Organization; Ministry of Public Health...Completed